Bryce has experience in both contentious and non-contentious matters across a range of IP rights and technical areas. Prior to undertaking his legal studies, Bryce obtained a degree in Chemistry and Applied Chemistry.  He has represented clients in the pharma and biotech fields as well as in the medical devices, gaming, banking and FMCG sectors.

He has particular experience as a patent litigator having conducted litigation across a wide range of technology areas in the UK and Europe, and prior to joining Powell Gilbert, South Africa and other African countries.

Bryce joined Powell Gilbert in 2016.

Key cases

• Edwards Lifesciences v Meril (medical devices – trancatheter heart valves)

• Biogen v Gedeon Richter (adalimumab formulations)

• Edwards Lifesciences v Boston Scientific (medical devices - transcatheter heart valves)

• Abbott v Edwards Lifesciences (medical devices – transcatheter mitral valve repair)

• Ansell v Reckitt Benckiser (synthetic polyisoprene products)

• Eli Lilly v Eisai (Alzheimer therapies)

• Biogen v AbbVie (adalimumab)

• Biogen v Fresenius (adalimumab formulations)

• Merck Shark & Dohme v GlaxoSmithKline (pneumococcal vaccines)